Madrigal Pharmaceuticals, Inc. (MDGL) vs Vaxcyte, Inc. (PCVX)
- Madrigal Pharmaceuticals, Inc. MDGL 449.74 −2.19%
- Vaxcyte, Inc. PCVX 63.62 −2.53%
Madrigal Pharmaceuticals, Inc. and Vaxcyte, Inc. are both Biotechnology companies. Madrigal Pharmaceuticals, Inc. and Vaxcyte, Inc. are of similar size ($10.6B and $10.3B). Vaxcyte, Inc. has the higher net margin (0.00% vs −25.3%) and the higher return on invested capital (−57.3% vs −787.3%). Across the 14 metrics below, Vaxcyte, Inc. leads on 9 and Madrigal Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | MDGL | PCVX | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.48% | 0.00% | 65.16% |
| Operating margin | (25.13%) | 0.00% | 0.00% |
| Net margin | (25.32%) | 0.00% | 0.00% |
| Free cash flow margin | (16.07%) | 0.00% | 0.00% |
| Return on equity | (53.31%) | (36.51%) | (56.36%) |
| Return on assets | (28.77%) | (33.03%) | (48.04%) |
| Return on invested capital | (787.33%) | (57.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack